期刊文献+

广州地区ALT不合格献血者再次献血血液筛查结果分析 被引量:7

The Result Analysis on the Second Donations of ALT Deferred Donors
原文传递
导出
摘要 目的探讨ALT筛查在无偿献血血液安全中的作用。方法采用回顾性调查方法,追踪广州地区2007-2008年ALT单项检测首次不合格的献血者再次献血时的血液筛查结果,并进行比较分析。结果2007-2008年广州地区9122位ALT单项检测首次不合格的献血者中,1005人(11%)再次来献血,其中,五项传染病指标全部标合格者747人(74.3%),258人(25.7%)不合格,其中ALT单项仍为阳性者240人,为不合格总人数的93%,有18人(7%)献血者传染病指标转为不合格,其中ALT阴性而其他四项指标不合格者15人,ALT合并其他传染病指标不合格者3人。结论ALT筛查在一定程度上能够减少肝炎病毒窗口期或隐匿性感染的漏检,在其他更敏感和特异的检测方法引入我国血液筛查之前,ALT筛查对降低输血传染病残留风险仍具有不可忽视的作用。 Objective To evaluate the importance of ALT blood screening on the blood safety. Method The blood screening results of ALT deferred donors during 2007 to 2008 in Guangzhou were traced and analyzed. Result In all 9122 ALT deferred donors, 1005 (11%) re-donated during 2007 to 2008, in which 747(74.3%) were qualified with all 5 blood screening tests on infectious diseases, and 258 (25.7%) were unqualified again with one or two of the tests. Among these 258 donors, 240(93%) were only ALT unqualified, other 18 (7%) were unqualified with specific infectious disease tests, in which 15 were ALT qualified and 3 were ALT unqualified. Conclusion ALT test could reduce the risk of hepatitis due to the window-period and other hidden infectious disease due to screening failure. Before more sensitive and specific new methods were introduced into blood screening, ALT plays an unnegligible role in reducing the risk of transfusion-transmitted diseases.
机构地区 广州血液中心
出处 《热带医学杂志》 CAS 2009年第6期661-662,680,共3页 Journal of Tropical Medicine
关键词 ALT 再次献血 血液筛查 ALT deferred donor blood screening
  • 相关文献

参考文献6

二级参考文献25

共引文献103

同被引文献60

  • 1徐东刚,孟宗达,逯好英,马贤凯,孙德贵,刘彩云,牛建章,田茶,陈淑芬,孙永德.输血后丙型肝炎病毒血症、抗体及转氨酶动态研究[J].中华实验和临床病毒学杂志,1994,8(4):340-343. 被引量:10
  • 2王良华,叶贤林,尚桂芳,周雄伟,周晓露.免疫筛查阴性献血者血样病毒核酸检测的研究[J].中国输血杂志,2005,18(4):286-289. 被引量:75
  • 3赵辉,谢尧,李明慧,徐道振,陆志檬,骆抗先,贾继东,王宇明,赵桂珍,张树林,张大志.慢性丙型肝炎患者的血清HCV基因型和RNA含量与ALT和AST水平不相关[J].中华检验医学杂志,2007,30(6):631-634. 被引量:33
  • 4刘赴平,何子毅,邹文涛,刘景春.无偿献血者丙氨酸氨基转氨酶阳性结果分析[J].中国基层医药,2007,14(5):783-785. 被引量:22
  • 5Van der Pocl C,Noel L,Bara J,et al.ISBA working party on transmissible diseases:report on the workshop infectious disease testing and quality control[J].Vox Sang,1996,70(1):53.
  • 6Brinkmann T,Dreier J,Diekmann J,et al.Alanine am-inotransferase cut-off values for blood donor screening using the new international federation of clinical chemistry reference method at 37 degrees C[J].Vox Sang,2003,85(2):159-164.
  • 7Phikulsod S,Oota S,Tirawatnapong T,et al.One-year experience of nucleic acid technology testing for human immunodeficiency virus type Ⅰ,hepatitis C virus,and hepatitis B virus in Thai blood donations[J].Transfusion,2009,49(6):1127-1135.
  • 8Yongshui F,Yuzhong W, Wenjie X, et aL New trends of HCV infec- tion in China revealed by geneticanalysis of viral sequences deter- mined from first-time volunteer blood donors. Journal of Viral Hepa- titis,2011,18( 1 ) :42-52.
  • 9Gevers TJ, Slavenburg S, van Oijen MG, et al. Treatment extension benefits HCV genotype t patients without rapid virological re- sponse:a systematic review. Neth J Med. 2011,69 (5) :216-221.
  • 10Ahmad A, Armin G, Federico M, et al. Uhra-Rapid Virological Re- sponse,young age,low c-GT/ALT ratio, and absence of steatosis i- dentify a subgroup of HCV genotype 3 patients who achieve SVR with IFN-a monotherapy. Dig Dis Sci,2011,56( ) :3296-3304.

引证文献7

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部